Catalyst Wire Dossier Catalyst Wire Dossier

Budesonide Orodispersible Tablet

budesonide · Dr. Falk Pharma GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Budesonide Orodispersible Tablet, covering 2017-02-03 to 2017-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis [Phase 3]

See pricing